
RAPP
Rapport Therapeutics Inc.
$26.11
-$0.25(-0.95%)
41
Overall
--
Value
41
Tech
--
Quality
Market Cap
$955.88M
Volume
415.64K
52W Range
$6.43 - $42.27
Target Price
$51.71
Order:
Income Statement
Metric | Trend | Chart | 2023 Dec | 2024 Dec |
---|---|---|---|---|
OPERATING EXPENSES | ||||
Operating Expenses | $36.2M | $83.1M | ||
Research & Development | -- | $60.9M | ||
Research Expense | -- | $60.9M | ||
Selling, General & Administrative | $36.2M | $22.1M | ||
General & Administrative Expenses | $36.2M | $22.1M | ||
Salaries & Wages | -- | $10.2M | ||
Depreciation & Amortization | -- | $800.0K | ||
Depreciation & Amortization | -- | $800.0K | ||
Other Operating Expenses | -- | $1.2M | ||
OPERATING INCOME | ||||
Operating income | $-36.2M | $-83.1M | ||
EBITDA | $-34.7M | $-76.8M | ||
NON-OPERATING ITEMS | ||||
Intinc | $2.5M | $12.1M | ||
Net Non-Operating Interest Income/Expense | $2.5M | $12.1M | ||
Other Income/Expense | $1.1M | $526.0K | ||
PRE-TAX INCOME | ||||
EBIT | $-34.8M | $-78.3M | ||
Pre-Tax Income | $-34.8M | $-78.3M | ||
INCOME TAX | ||||
Tax Provision | $10.0K | -- | ||
NET INCOME | ||||
Net Income | $-34.8M | $-78.3M | ||
Net Income (Continuing Operations) | $-34.8M | $-78.3M | ||
Net Income (Discontinued Operations) | $-34.8M | $-78.3M | ||
Net Income (Common Stockholders) | $-34.8M | $-78.3M | ||
Normalized Income | $-25.6M | -- | ||
TOTALS | ||||
Total Expenses | $36.2M | $83.1M | ||
SHARE & EPS DATA | ||||
Average Shares Outstanding | $1.5M | $20.7M | ||
Average Shares Outstanding (Diluted) | $1.5M | $20.7M | ||
Shares Outstanding | $36.5M | $36.5M | ||
Basic EPS | $-23.1 | $-3.78 | ||
Basic EPS (Continuing Operations) | $-23.1 | $-3.78 | ||
Diluted EPS | $-23.1 | $-3.78 | ||
Diluted EPS (Continuing Operations) | $-23.1 | $-3.78 | ||
OTHER METRICS | ||||
Gain On Sale Of P P E | -- | $-526.0K | ||
Other Gand A | $36.2M | $22.1M |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | RAPP | $26.11 | -0.9% | 415.64K |
3 | ||||
4 | ||||
5 | ||||
6 |
Get Rapport Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW